Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health, Inc. (HIMS)
:HIMS
HIMS Stock Chart & Stats
$35.56
-$0.61(-2.20%)
At close: 4:00 PM EST
$35.56
-$0.61(-2.20%)
Day’s Range― - ―
52-Week Range$23.97 - $72.98
Previous CloseN/A
Volume4.28M
Average Volume (3M)17.24M
Market Cap
$8.10B
Enterprise Value$14.59B
Total Cash (Recent Filing)$629.74M
Total Debt (Recent Filing)$1.12B
Price to Earnings (P/E)65.7
Beta2.68
Next Earnings
Mar 02, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding219,270,890
10 Day Avg. Volume11,796,140
30 Day Avg. Volume17,242,057
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)10.95
Price to Sales (P/S)3.54
P/FCF Ratio26.33
Enterprise Value/Market Cap1.80
Enterprise Value/Revenue6.60
Enterprise Value/Gross Profit8.80
Enterprise Value/Ebitda92.41
Forecast
1Y Price Target
$44.71Price Target Upside25.73% Upside
Rating ConsensusHold
Number of Analyst Covering11
EPS Forecast (FY)0.47
Revenue Forecast (FY)$2.35B
Bulls Say, Bears Say
Bulls Say
Shareholder ReturnsHIMS announced that its board of directors has authorized a share repurchase program of up to $250MM of outstanding Class A common stock over the next three years.
Strategic AcquisitionThe acquisition of YourBio Health supports the company’s ambition to bring at-home lab testing to the platform.
User EngagementHers MAUs grew 66% y/y, accelerating 24ppts m/m.
Bears Say
Competitive Pricing PressureThe starter doses of Wegovy/Ozempic are now the same price as HIMS’ compounded semaglutide, which is likely to pressure compounded GLP-1 adoption all else equal.
Order DeclineTotal orders declined ~18% y/y vs. ~16% y/y in October, reflecting an ~8% m/m decline.
Regulatory ConcernsThe bill introduced aims to curtail compounding practices by clarifying that any compounded drug containing the same active ingredient as an approved medicine is 'essentially a copy.'
Hims & Hers Health News
HIMS FAQ
What was Hims & Hers Health, Inc.’s price range in the past 12 months?
Hims & Hers Health, Inc. lowest stock price was $23.97 and its highest was $72.98 in the past 12 months.
What is Hims & Hers Health, Inc.’s market cap?
Hims & Hers Health, Inc.’s market cap is $8.10B.
When is Hims & Hers Health, Inc.’s upcoming earnings report date?
Hims & Hers Health, Inc.’s upcoming earnings report date is Mar 02, 2026 which is in 70 days.
How were Hims & Hers Health, Inc.’s earnings last quarter?
Hims & Hers Health, Inc. released its earnings results on Nov 03, 2025. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.094 by -$0.034.
Is Hims & Hers Health, Inc. overvalued?
According to Wall Street analysts Hims & Hers Health, Inc.’s price is currently Undervalued.
Does Hims & Hers Health, Inc. pay dividends?
Hims & Hers Health, Inc. does not currently pay dividends.
What is Hims & Hers Health, Inc.’s EPS estimate?
Hims & Hers Health, Inc.’s EPS estimate is 0.05.
How many shares outstanding does Hims & Hers Health, Inc. have?
Hims & Hers Health, Inc. has 219,270,890 shares outstanding.
What happened to Hims & Hers Health, Inc.’s price movement after its last earnings report?
Hims & Hers Health, Inc. reported an EPS of $0.06 in its last earnings report, missing expectations of $0.094. Following the earnings report the stock price went down -3.604%.
Which hedge fund is a major shareholder of Hims & Hers Health, Inc.?
Currently, no hedge funds are holding shares in HIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hims & Hers Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$44.71 (25.73% Upside)
$44.71 (25.73% Upside)
Blogger Sentiment
Bullish
HIMS Sentiment 70%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 2.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $97.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
34.90%
12-Months-Change
Fundamentals
Return on Equity
26.21%
Trailing 12-Months
Asset Growth
270.82%
Trailing 12-Months
Company Description
Hims & Hers Health, Inc.
Hims & Hers Health (HIMS) is a telehealth company focused on providing accessible healthcare solutions primarily for men and women. Founded in 2017, the company operates in the digital health sector, offering a range of products and services including prescription medications for conditions such as erectile dysfunction, hair loss, and skincare, as well as wellness products like vitamins and supplements. HIMS leverages a direct-to-consumer model, utilizing an online platform that allows customers to consult with licensed healthcare professionals and receive treatment through a convenient digital experience.
HIMS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a strong performance with significant revenue growth, strategic partnerships, and international expansion. However, there are challenges in gross margins and increased G&A costs. The company's strategy and future outlook remain optimistic.View all HIMS earnings summariesHIMS Revenue Breakdown
96.60% Online
3.40% Wholesale
HIMS Stock 12 Month Forecast
Average Price Target
$44.71
▲(25.73% Upside)
Technical Analysis
Ownership Overview
5.53% Insiders
25.43% Mutual Funds
23.42% Other Institutional Investors
24.23% Public Companies and Individual Investors